Puretech Health Plc (PRTC) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Puretech Health Plc  (NASDAQ: PRTC)

Puretech Health Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Puretech Health Plc in the fourth quarter 2025?
Puretech Health Plc recorded a cumulative net loss of $-110 million during 12 months ending in the fourth quarter 2025, resulting in a negative return on equity (ROE) of -36.01%.

Within the Major Pharmaceutical Preparations industry 156 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 0 to 3268.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change -25.07 % -25.07 % -0.17 % -25.07 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -110 28 28 28 28
Return On Equity (TTM) -36.01 % 8.39 % 7.79 % 7.78 % 7.26 %
PRTC's Total Ranking # 3268 # 0 # # #
Equity (TTM) in Millions 306 306 306 306 408
Seq. Equity Change 0 % 0 % 0 % -25.07 % 0 %
Seq. Net Income Change - - - - -

Back to PRTC Management Effectiveness >> PRTC's 5 Years Annual ROE >> Compare PRTC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 157
Sector # 381
Overall # 3268

Return On Equity Statistics
High Average Low
6.81 %
-9.96 %
-36.01 %
(Dec 31 2024)   (Dec 31 2025)





PRTC Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 306 408 458 548 584
Y / Y Equity Change -25.07 % -10.98 % -16.32 % -6.26 % -10.62 %
Net Income in Millions -110 28 -67 -37 -63
Y / Y Net Income Change - - - - -
Return On Equity -36.01 % 6.81 % -14.54 % -6.77 % -10.74 %

Back to PRTC Management Effectiveness >> PRTC's 5 Years Annual ROE >> Compare PRTC ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PRTC's' Return on Equity at Yahoo Finance
PRTC's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PRTC's Competitors
Subscribers only: Roe for Puretech Health Plc's Suppliers
Subscribers only: Return On Equity for PRTC's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.